Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
44.95
+0.16 (0.36%)
At close: Jun 26, 2026, 4:00 PM EDT
44.80
-0.15 (-0.34%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Definium Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Definium Therapeutics stock have an average target of 50.31, with a low estimate of 25 and a high estimate of 74. The average target predicts an increase of 11.92% from the current stock price of 44.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Definium Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 11 | 12 | 12 | 11 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 14 | 16 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +11.23% | Jun 23, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $61 → $74 | Buy | Reiterates | $61 → $74 | +64.63% | Jun 23, 2026 |
Christopher Chen Robert W. Baird | Robert W. Baird | Buy Maintains $37 → $57 | Buy | Maintains | $37 → $57 | +26.81% | Jun 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $38 → $60 | Buy | Maintains | $38 → $60 | +33.48% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +55.73% | Jun 22, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
27.33M
EPS This Year
-2.30
from -2.06
EPS Next Year
-1.59
from -2.30
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 190.5M | |
| Avg | n/a | 27.3M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 2,944.1% |
| Avg | - | 644.0% |
| Low | - | -52.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.85 | 0.30 | |
| Avg | -2.30 | -1.59 | |
| Low | -2.67 | -2.62 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.